000 01381 a2200397 4500
005 20250513124919.0
264 0 _c19971002
008 199710s 0 0 eng d
022 _a0002-9149
024 7 _a10.1016/s0002-9149(97)00437-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKereiakes, D J
245 0 0 _aPartial reversal of heparin anticoagulation by intravenous protamine in abciximab-treated patients undergoing percutaneous intervention.
_h[electronic resource]
260 _bThe American journal of cardiology
_cSep 1997
300 _a633-4 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAbciximab
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAngioplasty, Balloon, Coronary
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunoglobulin Fab Fragments
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPlatelet Aggregation Inhibitors
_xtherapeutic use
650 0 4 _aProtamines
_xtherapeutic use
700 1 _aBroderick, T M
700 1 _aWhang, D D
700 1 _aAnderson, L
700 1 _aFye, D
773 0 _tThe American journal of cardiology
_gvol. 80
_gno. 5
_gp. 633-4
856 4 0 _uhttps://doi.org/10.1016/s0002-9149(97)00437-2
_zAvailable from publisher's website
999 _c9273593
_d9273593